Department of Pediatric Endocrinology/Genetics, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200092, China.
Shanghai Institute for Pediatric Research, Shanghai, 200092, China.
BMC Med Genet. 2020 Apr 8;21(1):74. doi: 10.1186/s12881-020-01010-4.
PYGL mutations can cause liver phosphorylase deficiency, resulting in a glycogenolysis disorder, namely, glycogen storage disease (GSD) VI. The disease is rarely reported in the Chinese population. GSD VI is mainly characterized in untreated children by hepatomegaly, growth retardation and elevated liver transaminases.
In this study, we report two GSD VI patients with growth retardation and abnormal liver function. There was no obvious hepatomegaly for one of them. Whole exome sequencing (WES) combined with copy number variation analysis was performed. We found a novel homozygous gross deletion, c.1621-258_2178-23del, including exons 14-17 of PYGL in patient 1. The exons 14-17 deletion of PYGL resulted in an in-frame deletion of 186 amino acids. Compound heterozygous mutations of PYGL were identified in patient 2, including a novel missense mutation c.1832C > T/p.A611V and a recurrent nonsense mutation c.280C > T/p.R94X. After treatment with uncooked cornstarch (UCS) 8 months for patient 1 and 13 months for patient 2, the liver transaminases of both patients decreased to a normal range and their stature was improved. However, patient 1 still showed mild hypertriglyceridemia.
We describe two GSD VI patients and expand the spectrum of PYGL mutations. Patient 1 in this study is the first GSD VI case that showed increased transaminases without obvious hepatomegaly due to a novel homozygous gross deletion of PYGL identified through WES.
PYGL 突变可导致肝磷酸化酶缺乏,从而导致糖原分解障碍,即糖原贮积症(GSD)VI。这种疾病在中国人群中很少见报道。未经治疗的儿童 GSD VI 主要表现为肝肿大、生长迟缓、肝转氨酶升高。
本研究报道了两名 GSD VI 患者,均表现为生长迟缓和肝功能异常。其中一名患者无明显肝肿大。对患者进行全外显子组测序(WES)结合拷贝数变异分析,发现患者 1 存在 PYGL 第 14-17 外显子的纯合大片段缺失,c.1621-258_2178-23del,导致 186 个氨基酸的框内缺失。患者 2 携带 PYGL 的复合杂合突变,包括新的错义突变 c.1832C>T/p.A611V 和反复出现的无义突变 c.280C>T/p.R94X。患者 1 和 2 分别接受生玉米淀粉(UCS)治疗 8 个月和 13 个月后,肝转氨酶均降至正常范围,身高得到改善。但患者 1 仍存在轻度高甘油三酯血症。
我们描述了两名 GSD VI 患者,扩展了 PYGL 突变谱。本研究中的患者 1 是首例因 PYGL 纯合大片段缺失导致的 WES 检测到的仅表现为转氨酶升高而无明显肝肿大的 GSD VI 病例。